Maintaining intimacy for prostate cancer patients on androgen deprivation therapy

被引:16
|
作者
Wassersug, Richard J. [1 ,2 ]
机构
[1] Dalhousie Univ, Dept Med Neurosci, Halifax, NS B3H 3J5, Canada
[2] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, 215 Franklin St, Melbourne, Vic 3000, Australia
关键词
androgen deprivation therapy; couples; intimacy; prostate cancer; sexuality; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; SEXUAL RECOVERY; PSYCHOSOCIAL INTERVENTIONS; RADICAL PROSTATECTOMY; HORMONE-THERAPY; MEN; ADJUSTMENT; PARTNERS; EXERCISE;
D O I
10.1097/SPC.0000000000000190
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose of reviewAndrogen deprivation therapy (ADT) causes erectile dysfunction and increases patients' emotionality while diminishing their sexual interest. ADT has been linked to erosion of spousal bonds; however, this is not an invariant outcome. Understanding the factors that lead to these various outcomes may help couples deal with ADT.Recent findingsA subset of couples report that they became closer as a result of the patients going on ADT. Recent data suggest that what helps couples most is preemptive awareness of ADT's side-effects and congruence in how patients and their partners understand and accept the psychosexual impact of ADT. Sex therapy for prostate cancer patients divides along gendered lines, with distinctly male' (recovery of erections) and female' (promoting sexual practices that are not erection dependent) approaches. Unfortunately, neither is very effective for couples when the patient is on ADT. Options beyond the standard gendered framework, such as use of an external penile prosthesis, may be worth offering to ADT patients trying to find a new normal' that is sexually rewarding for them.SummaryIntimacy is sharing something with someone that one shares with no one else. Exploring novel sexual practices can help couples stay intimate, even when the patient is on ADT.
引用
收藏
页码:55 / 65
页数:11
相关论文
共 50 条
  • [1] Androgen deprivation therapy and statin therapy in prostate cancer patients
    Lai, Kin Chung
    Turknett, Toiya
    Singh, Parminder
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [2] Reversibility of androgen deprivation therapy in patients with prostate cancer
    Fridmans, A
    Chertin, B
    Koulikov, D
    Lindenberg, T
    Gelber, H
    Leiter, C
    Farkas, A
    Spitz, IM
    [J]. JOURNAL OF UROLOGY, 2005, 173 (03): : 784 - 789
  • [3] Sexuality and Intimacy After Definitive Treatment and Subsequent Androgen Deprivation Therapy for Prostate Cancer
    Higano, Celestia S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30) : 3720 - 3725
  • [4] Androgen Deprivation Therapy for Prostate Cancer
    Pagliarulo, Vincenzo
    [J]. MOLECULAR & DIAGNOSTIC IMAGING IN PROSTATE CANCER: CLINICAL APPLICATIONS AND TREATMENT STRATEGIES, 2019, 1126 : 1 - 30
  • [5] Androgen deprivation therapy for prostate cancer
    Das, Manjulika
    [J]. LANCET ONCOLOGY, 2017, 18 (10): : E567 - E567
  • [6] Androgen deprivation therapy for prostate cancer
    Sharifi, N
    Gulley, JL
    Dahut, WL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (02): : 238 - 244
  • [7] Androgen deprivation therapy for prostate cancer
    Bahnson, Robert
    [J]. JOURNAL OF UROLOGY, 2007, 178 (04): : 1148 - 1148
  • [8] Androgen deprivation therapy for prostate cancer
    Singer, Eric A.
    Golijanin, Dragan J.
    Miyamoto, Hiroshi
    Messing, Edward M.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (02) : 211 - 228
  • [9] The influence of an androgen deprivation therapy educational program on dyadic quality and intimacy for prostate cancer patients and their partners.
    Wibowo, Erik
    Wassersug, Richard J.
    Robinson, John W.
    Matthew, Andrew
    McLeod, Deborah L.
    Walker, Lauren M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07)
  • [10] Fracture risk in patients with prostate cancer on androgen deprivation therapy
    López, AM
    Pena, MA
    Hernández, R
    Val, F
    Martín, B
    Riancho, JA
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (06) : 707 - 711